-transparent.png){kind=logo}
Atrial natriuretic factor (isoleucine ANF 101-126), cleaved ANF (isoleucine ANF 101-105/106-126) and des (Gln 18, Ser 19, Gly 20, Leu 21, Gly 22) ANF 4-23-NH2 (C-ANF 4-23) stimulated cyclic guanosine monophosphate production (cGMP) by rat aortic vascular smooth muscle cells (VSMC) in culture. Cleaved ANF and ANF C4-23 also antagonised or diminished the response to ANF 101-126. Agonist and antagonist actions of both peptides were dose-related. In contrast, prepro ANF (104-123), an ANF precursor fragment, exhibited no agonist or antagonist effect on cGMP production.
Related Publications
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
April 1998,
Gastroenterology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
June 1998,
The Annals of thoracic surgery,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
December 1982,
Neuropharmacology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
January 2021,
Frontiers in microbiology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
July 2010,
Autonomic & autacoid pharmacology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
January 1974,
Naunyn-Schmiedeberg's archives of pharmacology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
April 1994,
Biochemical medicine and metabolic biology,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
January 1994,
The Clinical investigator,
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
July 1976,
Science (New York, N.Y.),
T J Abell, and
A M Richards, and
T G Yandle, and
E A Espiner, and
C Frampton, and
H Ikram
April 2002,
Journal of endocrinological investigation,
